Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues |
| Diagnostics | | 17,963.0 | 16,916.0 | 15,644.0 | 15,518.0 | 14,246.0 | 12,993.0 | 10,805.0 |
| Nutritionals | | 7,997.0 | 8,152.0 | 8,294.0 | 8,188.0 | 8,004.0 | 7,779.0 | 7,647.0 |
| Established Pharmaceuticals | | 4,838.0 | 4,795.0 | 4,718.0 | 4,662.0 | 4,496.0 | 4,329.0 | 4,303.0 |
| |
| EBITDA |
| Diagnostics | | 7,753.0 | 7,124.0 | 6,256.0 | 6,352.0 | 5,575.0 | 5,021.0 | 3,725.0 |
| Nutritionals | | 1,287.0 | 1,547.0 | 1,763.0 | 1,812.0 | 1,775.0 | 1,759.0 | 1,751.0 |
| Established Pharmaceuticals | | 1,000.0 | 962.0 | 889.0 | 888.0 | 796.0 | 782.0 | 794.0 |
| |
| EBIT |
| Diagnostics | | 7,753.0 | 7,124.0 | 6,256.0 | 6,352.0 | 5,575.0 | 5,021.0 | 3,725.0 |
| Nutritionals | | 1,287.0 | 1,547.0 | 1,763.0 | 1,812.0 | 1,775.0 | 1,759.0 | 1,751.0 |
| Established Pharmaceuticals | | 1,000.0 | 962.0 | 889.0 | 888.0 | 796.0 | 782.0 | 794.0 |
| |
| Mix |
| Diagnostics | | 39.4% | 38.0% | 36.3% | 36.7% | 35.4% | 34.8% | 31.2% |
| Nutritionals | | 17.6% | 18.3% | 19.3% | 19.4% | 19.9% | 20.8% | 22.1% |
| Established Pharmaceuticals | | 10.6% | 10.8% | 11.0% | 11.0% | 11.2% | 11.6% | 12.4% |
| |
| Growth |
| Diagnostics | | 26.1% | 30.2% | 44.8% | 82.2% | 82.9% | 68.8% | 40.1% |
| Nutritionals | | -0.1% | 4.8% | 8.5% | 8.0% | 6.3% | 3.4% | 3.2% |
| Established Pharmaceuticals | | 7.6% | 10.8% | 9.6% | 7.7% | 1.2% | -4.6% | -4.1% |
|